Other top stories

Mental Health Counseling Approach Meets College Students Where They Live

May 10, 2023

Death on a NYC Subway Highlights Need for Urgent Action on Homelessness, Mental Health

May 9, 2023

The Advantages of Long-Acting Injectables in Early-Phase Schizophrenia

May 8, 2023

Smiley Emojis Sometimes Mask Sad Feelings, Study Finds

May 8, 2023

The Weekly Mind Reader: Ghrelin, Anxiety, and Disordered Eating

May 5, 2023

Experimental Alzheimer's Drug Donanemab Shows Promise in Slowing Cognitive Decline

May 4, 2023

Other stories

A Reason for Hope in Rett Syndrome: New Medications, Novel Gene Therapies

May 3, 2023

Slow-Release UZEDY Gains FDA Approval, Reduces Schizophrenia Relapse by 80%

May 2, 2023

Pediatric Brain Abscess Mystery Cluster in Nevada Worries Investigators

May 1, 2023

The Weekly Mind Reader: Fast New Mood Screener

April 28, 2023

Dog Walking Linked to Surprisingly High Risk of Traumatic Brain Injury

April 27, 2023

Qalsody is First Drug for Rare Form of ALS Approved by FDA

April 26, 2023

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe